Biochemical Response to Treatment of Bone Hyperresorption in Chronically Critically Ill Patients

This publication has 17 references indexed in Scilit:

• Bone Hyperresorption Is Prevalent in Chronically Critically III Patients
  Chest, 1998
• TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
  Endocrinology and Metabolism Clinics of North America, 1998
• Bisphosphonates: Mechanisms of Action
  Endocrine Reviews, 1998
• Urinary N-Telopeptide Levels Discriminate Normal, Osteopenic, and Osteoporotic Bone Mineral Density
  Archives of internal medicine (1960), 1997
• Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone Mineral Density
  The American Journal of Medicine, 1997
• Survival Experience of Chronically Critically Ill Patients
  Nursing Research, 1996
• Bone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation. A review
  Spinal Cord, 1995
• Weaning From Prolonged Mechanical Ventilation
  Chest, 1994
• Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover
  Calcified Tissue International, 1994
• A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
  Journal of Bone and Mineral Research, 1992